
    
      The identification of alternative therapies with the capacity to dampen inflammatory
      processes and reduce serum cholesterol takes on additional significance given independent
      concerns about heightened cardiovascular risk in schizophrenia patients, through exposure to
      antipsychotic drugs, increased cholesterol levels, metabolic syndrome and obesity, and
      smoking.
    
  